Adolescent triple-negative breast cancer with germline pathogenic variants in both BRCA1 and TP53 genes: A case report
Almost 5-10% of breast cancer results from inherited genetic pathogenic variants. Patients with pathogenic variants in high-penetrance genes such as TP53, BRCA1 and BRCA2 are susceptible to breast cancer. Moreover, nearly 80% of BRCA pathogenic variants carriers are diagnosed with breast cancer at a...
Main Authors: | Dongmei Chen, Chenyang Zhang, Mengqi Yuan, Ying Zhang, Qing Liu, Donggui Wan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.970641/full |
Similar Items
-
A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2
by: Miyuki Kitahara, et al.
Published: (2021-11-01) -
Study on tumour suppressor gene TP53 mutation and prognosis in patients with triple-negative breast cancer
by: YANG Cuiyan, WANG Haoyu, CHEN Xiaosong, SHEN Kunwei
Published: (2022-09-01) -
Metaplastic carcinoma of the breast and BRCA1 germline mutation: a case report and review
by: Michiko Yamashita, et al.
Published: (2021-01-01) -
Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history
by: Christoph Engel, et al.
Published: (2018-03-01) -
Triple-negative breast cancer arising in a fibroadenoma in BRCA 1 mutated patient
by: Nicole Brunetti, et al.
Published: (2023-01-01)